nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—osteoarthritis	0.933	1	CbGaD
Etodolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00401	0.06	CbGpPWpGaD
Etodolac—RXRA—Vitamin A and Carotenoid Metabolism—ALDH1A2—osteoarthritis	0.00391	0.0585	CbGpPWpGaD
Etodolac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00319	0.0477	CbGpPWpGaD
Etodolac—PTGS1—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00261	0.039	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—FRZB—osteoarthritis	0.00213	0.0318	CbGpPWpGaD
Etodolac—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00207	0.031	CbGpPWpGaD
Etodolac—UGT1A10—Metapathway biotransformation—GSTO1—osteoarthritis	0.00167	0.025	CbGpPWpGaD
Etodolac—PTGS1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00145	0.0217	CbGpPWpGaD
Etodolac—UGT1A3—Phase II conjugation—GSTO1—osteoarthritis	0.00115	0.0173	CbGpPWpGaD
Etodolac—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00115	0.0172	CbGpPWpGaD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—LEP—osteoarthritis	0.00113	0.0169	CbGpPWpGaD
Etodolac—UGT2B7—Phase II conjugation—GSTO1—osteoarthritis	0.000981	0.0147	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—CRP—osteoarthritis	0.00092	0.0138	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—FN1—osteoarthritis	0.000849	0.0127	CbGpPWpGaD
Etodolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.000847	0.0127	CbGpPWpGaD
Etodolac—UGT1A9—Phase II conjugation—GSTO1—osteoarthritis	0.000797	0.0119	CbGpPWpGaD
Etodolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.000787	0.0118	CbGpPWpGaD
Etodolac—RXRA—a6b1 and a6b4 Integrin signaling—IL1A—osteoarthritis	0.000777	0.0116	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000762	0.0114	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	0.00073	0.0109	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	0.00071	0.0106	CbGpPWpGaD
Etodolac—RXRA—Nuclear Receptors—ESR1—osteoarthritis	0.000695	0.0104	CbGpPWpGaD
Etodolac—UGT1A3—Biological oxidations—GSTO1—osteoarthritis	0.000675	0.0101	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	0.000674	0.0101	CbGpPWpGaD
Etodolac—UGT1A3—Metapathway biotransformation—GSTO1—osteoarthritis	0.000666	0.00996	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—PTGS2—osteoarthritis	0.000617	0.00923	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000598	0.00895	CbGpPWpGaD
Etodolac—UGT2B7—Biological oxidations—GSTO1—osteoarthritis	0.000574	0.00858	CbGpPWpGaD
Etodolac—UGT2B7—Metapathway biotransformation—GSTO1—osteoarthritis	0.000566	0.00847	CbGpPWpGaD
Etodolac—RXRA—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	0.000549	0.00822	CbGpPWpGaD
Etodolac—RXRA—Biological oxidations—GSTO1—osteoarthritis	0.000535	0.00801	CbGpPWpGaD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—TNF—osteoarthritis	0.000521	0.0078	CbGpPWpGaD
Etodolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.00052	0.00779	CbGpPWpGaD
Etodolac—PTGS1—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.000511	0.00765	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—BMP2—osteoarthritis	0.000507	0.00759	CbGpPWpGaD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000502	0.00751	CbGpPWpGaD
Etodolac—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoarthritis	0.000488	0.00731	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000475	0.0071	CbGpPWpGaD
Etodolac—UGT1A9—Biological oxidations—GSTO1—osteoarthritis	0.000466	0.00698	CbGpPWpGaD
Etodolac—UGT1A9—Metapathway biotransformation—GSTO1—osteoarthritis	0.00046	0.00688	CbGpPWpGaD
Etodolac—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoarthritis	0.000456	0.00682	CbGpPWpGaD
Etodolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.000428	0.0064	CbGpPWpGaD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—IL6—osteoarthritis	0.000421	0.00629	CbGpPWpGaD
Etodolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.000418	0.00626	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—TNF—osteoarthritis	0.000416	0.00623	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—osteoarthritis	0.000414	0.00619	CbGpPWpGaD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00039	0.00584	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—GSTO1—osteoarthritis	0.00038	0.00569	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	0.000376	0.00563	CbGpPWpGaD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000364	0.00545	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000347	0.00519	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000336	0.00503	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.000336	0.00503	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	0.00033	0.00494	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—HSPA5—osteoarthritis	0.000319	0.00478	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—SMAD3—osteoarthritis	0.000318	0.00476	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.000304	0.00455	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—TIMP1—osteoarthritis	0.000304	0.00455	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000292	0.00436	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.00029	0.00434	CbGpPWpGaD
Etodolac—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000284	0.00425	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—LEP—osteoarthritis	0.000272	0.00407	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.00027	0.00404	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00027	0.00403	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—CRP—osteoarthritis	0.000268	0.00401	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.000267	0.00399	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—COL9A2—osteoarthritis	0.000262	0.00392	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—COL9A1—osteoarthritis	0.000254	0.00381	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000254	0.0038	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000252	0.00377	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IGF1—osteoarthritis	0.000225	0.00336	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.000219	0.00328	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—CRP—osteoarthritis	0.000218	0.00326	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000214	0.0032	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000207	0.0031	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoarthritis	0.000205	0.00307	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000203	0.00303	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—FMOD—osteoarthritis	0.000201	0.00301	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.0002	0.00299	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000197	0.00295	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—osteoarthritis	0.000191	0.00286	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000191	0.00286	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000181	0.00271	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—CRP—osteoarthritis	0.000173	0.00259	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—FN1—osteoarthritis	0.000173	0.00258	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—FMOD—osteoarthritis	0.000171	0.00256	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000168	0.00252	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL1B—osteoarthritis	0.000167	0.0025	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.000166	0.00248	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000165	0.00247	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000164	0.00246	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	0.000164	0.00246	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGES—osteoarthritis	0.000164	0.00245	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000163	0.00244	CbGpPWpGaD
Etodolac—RXRA—Metabolism—FMOD—osteoarthritis	0.000159	0.00238	CbGpPWpGaD
Etodolac—UGT1A3—NRF2 pathway—TGFB1—osteoarthritis	0.000155	0.00232	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.000152	0.00228	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—IGF1—osteoarthritis	0.000151	0.00226	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000149	0.00224	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.000144	0.00216	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.000142	0.00212	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGES—osteoarthritis	0.000139	0.00208	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—FMOD—osteoarthritis	0.000139	0.00208	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000137	0.00205	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL1B—osteoarthritis	0.000136	0.00204	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000135	0.00202	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TGFB1—osteoarthritis	0.000135	0.00202	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000134	0.002	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000133	0.00199	CbGpPWpGaD
Etodolac—UGT2B7—NRF2 pathway—TGFB1—osteoarthritis	0.000132	0.00197	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGES—osteoarthritis	0.00013	0.00194	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TNF—osteoarthritis	0.000126	0.00188	CbGpPWpGaD
Etodolac—RXRA—NRF2 pathway—TGFB1—osteoarthritis	0.000123	0.00184	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	0.000122	0.00183	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	0.000121	0.00182	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—SMAD3—osteoarthritis	0.000116	0.00174	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000116	0.00174	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTO1—osteoarthritis	0.000115	0.00173	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—FMOD—osteoarthritis	0.000113	0.00169	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGES—osteoarthritis	0.000113	0.00169	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—BGN—osteoarthritis	0.000112	0.00167	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	0.00011	0.00165	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—SMAD3—osteoarthritis	0.000109	0.00164	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000109	0.00163	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000108	0.00162	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000108	0.00161	CbGpPWpGaD
Etodolac—PTGS2—Disease—FMOD—osteoarthritis	0.000107	0.00161	CbGpPWpGaD
Etodolac—UGT1A9—NRF2 pathway—TGFB1—osteoarthritis	0.000107	0.0016	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	0.000106	0.00158	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IL6—osteoarthritis	0.000102	0.00152	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	9.96e-05	0.00149	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	9.91e-05	0.00148	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TNF—osteoarthritis	9.87e-05	0.00148	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	9.86e-05	0.00147	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTO1—osteoarthritis	9.81e-05	0.00147	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	9.79e-05	0.00147	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	9.69e-05	0.00145	CbGpPWpGaD
Etodolac—PTGS2—Disease—IHH—osteoarthritis	9.56e-05	0.00143	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—BGN—osteoarthritis	9.5e-05	0.00142	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—ESR1—osteoarthritis	9.48e-05	0.00142	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—LEP—osteoarthritis	9.35e-05	0.0014	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	9.32e-05	0.00139	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	9.25e-05	0.00138	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGES—osteoarthritis	9.23e-05	0.00138	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTO1—osteoarthritis	9.15e-05	0.00137	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—TGFB1—osteoarthritis	9.07e-05	0.00136	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—FMOD—osteoarthritis	8.98e-05	0.00134	CbGpPWpGaD
Etodolac—RXRA—Metabolism—BGN—osteoarthritis	8.86e-05	0.00133	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	8.64e-05	0.00129	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	8.21e-05	0.00123	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTO1—osteoarthritis	7.97e-05	0.00119	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL6—osteoarthritis	7.97e-05	0.00119	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	7.84e-05	0.00117	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	7.82e-05	0.00117	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—BGN—osteoarthritis	7.72e-05	0.00116	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	7.67e-05	0.00115	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	7.65e-05	0.00115	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP2—osteoarthritis	7.48e-05	0.00112	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTGES—osteoarthritis	7.32e-05	0.0011	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HSPA5—osteoarthritis	7.3e-05	0.00109	CbGpPWpGaD
Etodolac—ALB—Metabolism—FMOD—osteoarthritis	7.27e-05	0.00109	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFBI—osteoarthritis	7.13e-05	0.00107	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TIMP1—osteoarthritis	6.95e-05	0.00104	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	6.71e-05	0.001	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTO1—osteoarthritis	6.5e-05	0.000973	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	6.33e-05	0.000947	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—BGN—osteoarthritis	6.29e-05	0.000942	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	6.19e-05	0.000926	CbGpPWpGaD
Etodolac—PTGS2—Disease—GSTO1—osteoarthritis	6.16e-05	0.000922	CbGpPWpGaD
Etodolac—PTGS2—Disease—BGN—osteoarthritis	5.97e-05	0.000893	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FMOD—osteoarthritis	5.95e-05	0.00089	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGES—osteoarthritis	5.93e-05	0.000887	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	5.72e-05	0.000856	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—osteoarthritis	5.62e-05	0.000841	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SMAD3—osteoarthritis	5.6e-05	0.000837	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	5.59e-05	0.000836	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	5.22e-05	0.00078	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTO1—osteoarthritis	5.16e-05	0.000772	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—BGN—osteoarthritis	5e-05	0.000748	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	4.98e-05	0.000746	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGES—osteoarthritis	4.85e-05	0.000726	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TGFB1—osteoarthritis	4.63e-05	0.000693	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ESR1—osteoarthritis	4.57e-05	0.000683	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—osteoarthritis	4.33e-05	0.000647	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MMP1—osteoarthritis	4.32e-05	0.000647	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTO1—osteoarthritis	4.17e-05	0.000625	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	4.06e-05	0.000608	CbGpPWpGaD
Etodolac—ALB—Metabolism—BGN—osteoarthritis	4.04e-05	0.000605	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	4.02e-05	0.000602	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FN1—osteoarthritis	3.95e-05	0.00059	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—osteoarthritis	3.49e-05	0.000522	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IGF1—osteoarthritis	3.46e-05	0.000517	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTO1—osteoarthritis	3.42e-05	0.000511	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BGN—osteoarthritis	3.31e-05	0.000495	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—osteoarthritis	3.21e-05	0.000481	CbGpPWpGaD
Etodolac—PTGS2—Disease—SMAD3—osteoarthritis	2.93e-05	0.000438	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—osteoarthritis	2.73e-05	0.000409	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.61e-05	0.000391	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—osteoarthritis	2.55e-05	0.000381	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—osteoarthritis	2.22e-05	0.000332	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.14e-05	0.00032	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—osteoarthritis	2.07e-05	0.00031	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—osteoarthritis	1.81e-05	0.000271	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—osteoarthritis	1.24e-05	0.000186	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—osteoarthritis	1.16e-05	0.000174	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—osteoarthritis	9.51e-06	0.000142	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—osteoarthritis	9.35e-06	0.00014	CbGpPWpGaD
